GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:PERCF) » Definitions » Deferred Policy Acquisition Costs

PERCF (Percheron Therapeutics) Deferred Policy Acquisition Costs


View and export this data going back to . Start your Free Trial

What is Percheron Therapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Percheron Therapeutics Business Description

Traded in Other Exchanges
Address
14 Wallace Avenue, LEVEL 1, Toorak, VIC, AUS, 3142
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.